| orphan drug |
An orphan drug is any drug developed under the 1983 U.S. Orphan Drug Act, which concerns drugs for orphan diseases, namely such affecting less than 200,000 people in the US. This has been adopted as a subclause of the FDA. Developing a drug for groups that small would be financially unsound. Therefore, development of drugs for such diseases is rewarded by tax reductions and a monopoly for that drug for a limited time (7 years). ...
출처: en.wikipedia.org/wiki/Orphan_drug
|
|---|---|
| orphan drug |
A drug that treats a rare disease.
출처: www.genpromag.com/Glossary~LETTER~O.html
|
| orphan drug |
a status granted by the FDA to unpatentable medications developed for rare diseases. Orphan drug status gives the drug's manufacturer a seven-year right to exclusively market the compound. This protection of unpatentable orphan drugs encourages their development by greatly increasing their profitability.
출처: www.gmhc.org/health/glossary3.html
|
| orphan drug |
An FDA term for classification of a drug. Indicated for rare diseases. Gives the exclusive right to produce a drug that will be used by only an estimated small number of patients.
출처: www.aidsinfobbs.org/letters/27.html
|
| orphan drug |
The Orphan Drug program provides incentives for companies to develop and market drugs for diseases for which the number of patients afflicted with the disease is very small.
출처: www.inovio.com/glossary/
|